Oruka Therapeutics stock surges as ORKA-001 psoriasis trial success puts $1.1bn biotech strategy to the test
Read More Technology News Can Luxxfolio Holdings Inc.’s move into Litecoin mining sustain its aggressive LTC per share expansion strategy? Luxxfolio Holdings Inc. has launched Litecoin mining operations. Find out how this move could impact its aggressive LTC per share strategy. bySoujanya RaviFebruary 11, 2026